DexCom, Inc.
DXCM
$77.84
-$1.67-2.10%
| Weiss Ratings | DXCM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | C+ | |||
| Rating Factors | DXCM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Excellent | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | DXCM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.28 | |||
| Price History | DXCM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -13.42% | |||
| 30-Day Total Return | -11.24% | |||
| 60-Day Total Return | 0.15% | |||
| 90-Day Total Return | 3.99% | |||
| Year to Date Total Return | -0.84% | |||
| 1-Year Total Return | -41.58% | |||
| 2-Year Total Return | -31.61% | |||
| 3-Year Total Return | -26.01% | |||
| 5-Year Total Return | 16.82% | |||
| 52-Week High % Change | -44.01% | |||
| 52-Week Low % Change | 27.54% | |||
| Price | DXCM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $142.00 | |||
| 52-Week Low Price | $62.34 | |||
| 52-Week Low Price (Date) | Jul 26, 2024 | |||
| 52-Week High Price (Date) | Mar 26, 2024 | |||
| Valuation | DXCM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 31.07B | |||
| Enterprise Value | 31.08B | |||
| Price/Earnings (TTM) | 55.81 | |||
| Earnings Per Share (TTM) | 1.42 | |||
| Earnings Per Share Growth | 8.69% | |||
| Price/Earnings To Growth | 6.42 | |||
| Price/Sales (TTM) | 8.02 | |||
| Price/Book (Q) | 14.77 | |||
| Enterprise Value/Revenue (TTM) | 7.71 | |||
| Price | $77.84 | |||
| Enterprise Value/EBITDA (TTM) | 38.01 | |||
| Enterprise Value/EBIT | 51.81 | |||
| Market Cap Category | Large Cap | |||
| Dividends and Shares | DXCM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 406.70M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | DXCM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | (858) 200-0200 | |||
| Address | 6340 Sequence Drive San Diego, CA 92121 | |||
| Website | www.dexcom.com/global | |||
| Country | United States | |||
| Year Founded | 1999 | |||
| Profitability | DXCM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 14.87% | |||
| Profit Margin | 14.28% | |||
| Management Effectiveness | DXCM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 5.88% | |||
| Return on Equity | 27.63% | |||
| Income Statement | DXCM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 4.03B | |||
| Total Revenue (TTM) | 4.03B | |||
| Revenue Per Share | $9.92 | |||
| Gross Profit (TTM) | 2.44B | |||
| EBITDA (TTM) | 817.70M | |||
| EBIT (TTM) | 600.00M | |||
| Net Income (TTM) | 576.20M | |||
| Net Income Avl. to Common (TTM) | 576.20M | |||
| Total Revenue Growth (Q YOY) | 7.64% | |||
| Earnings Growth (Q YOY) | -40.81% | |||
| EPS Diluted (TTM) | 1.42 | |||
| EPS Diluted Growth (Q YOY) | -39.07% | |||
| Balance Sheet | DXCM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 2.58B | |||
| Cash Per Share (Q) | $6.34 | |||
| Total Current Assets (Q) | 4.30B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 2.10B | |||
| Current Ratio (Q) | 1.467 | |||
| Book Value Per Share (Q) | $5.38 | |||
| Total Assets (Q) | 6.48B | |||
| Total Current Liabilities (Q) | 2.93B | |||
| Total Debt (Q) | 2.59B | |||
| Total Liabilities (Q) | 4.38B | |||
| Total Common Equity (Q) | 2.10B | |||
| Cash Flow | DXCM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -207.50M | |||
| Cash from Financing (TTM) | -734.80M | |||
| Net Change in Cash (TTM) | 39.80M | |||
| Levered Free Cash Flow (TTM) | 557.43M | |||
| Cash from Operations (TTM) | 989.50M | |||
